lapatinib
Showing 351 - 371 of 371
Cancer Trial in United States (Oral lapatinib tablets or tablets)
Terminated
- Cancer
- Oral lapatinib tablets or placebo tablets
-
Denver, Colorado
- +19 more
Jun 7, 2012
Solid Tumor Trial in United States (drug, genetic, other)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- lapatinib ditosylate
- +12 more
-
Duarte, California
- +3 more
Apr 17, 2012
Relapsed Breast Cancer, Tumors, Breast Trial in United States (Lapatinib, Capecitabine, Docetaxel)
Terminated
- Relapsed Breast Cancer
- Neoplasms, Breast
- Lapatinib
- +3 more
-
Hot Springs, Arkansas
- +27 more
May 31, 2012
Solid Tumor Trial in United States (ixabepilone, lapatinib ditosylate)
Terminated
- Unspecified Adult Solid Tumor, Protocol Specific
- ixabepilone
- lapatinib ditosylate
-
Duarte, California
- +3 more
Mar 27, 2012
Tumors, Breast Trial in Italy, United Kingdom (LAPATINIB)
Terminated
- Neoplasms, Breast
- LAPATINIB
-
Rimini, Emilia-Romagna, Italy
- +9 more
Mar 22, 2012
Breast Cancer Trial in United States (apricoxib + lapatinib + capecitabine, + lapatinib + capecitabine)
Terminated
- Breast Cancer
- apricoxib + lapatinib + capecitabine
- placebo + lapatinib + capecitabine
-
Tucson, Arizona
- +43 more
Mar 13, 2012
Breast Cancer Trial in Goyang-si (paclitaxel, gemcitabine, lapatinib)
Completed
- Breast Cancer
- paclitaxel, gemcitabine, lapatinib
-
Goyang-si, Gyeonggi-do, Korea, Republic ofNational Cancer Center
Jan 1, 2012
Cancer Trial in Clermont-Ferrand (Evaluation of adherence to 3 oral anticancer treatment using a " Medication Event Monitoring
Completed
- Cancer
- Evaluation of adherence to 3 oral anticancer treatment using a " Medication Event Monitoring System "
-
Clermont-Ferrand, FranceCentre Jean Perrin
Aug 8, 2012
Sorafenib or Regorafenib on P63 Expression and Keratinocyte
Terminated
- Renal Cell Carcinoma
- +2 more
- skin punch biopsy
-
Lebanon, New Hampshire
- +1 more
Apr 11, 2013
Recurrent Endometrial Cancer Trial (Lapatinib and ixempra)
Unknown status
- Recurrent Endometrial Cancer
- Lapatinib and ixempra
- (no location specified)
Oct 18, 2011
Ovarian Epithelial Cancer Stage III, Stage IV Ovarian Cancer, Stage IV Breast Cancer Trial in Albuquerque, Seattle (lapatinib
Completed
- Ovarian Epithelial Cancer Stage III
- +2 more
- lapatinib (GW572016)
- +2 more
-
Albuquerque, New Mexico
- +1 more
Feb 16, 2011
Squamous Cell Carcinoma of Head and Neck Trial in Worldwide (Lapatinib oral tablets, Placebo)
Completed
- Squamous Cell Carcinoma of Head and Neck
- Lapatinib oral tablets
- Placebo
-
Caen, France
- +8 more
Apr 1, 2010
Ovarian Cancer Trial in Birmingham, Indianapolis (lapatinib)
Terminated
- Ovarian Cancer
- lapatinib
-
Birmingham, Alabama
- +1 more
Dec 10, 2009
Metastatic Breast Cancer Trial in Italy (Trastuzumab or Lapatinib)
Unknown status
- Metastatic Breast Cancer
- Trastuzumab or Lapatinib
-
Orbassano, Torino, Italy
- +3 more
Jun 25, 2009
Adenocarcinoma Trial in Netherlands, Peru, United States (Lapatinib (GW572016) oral tablets)
Completed
- Adenocarcinoma
- Lapatinib (GW572016) oral tablets
-
Los Angeles, California
- +5 more
May 15, 2009
Metastatic Breast Cancer Trial in Taipei (Bevacizumab, docetaxel, cisplatin)
Completed
- Metastatic Breast Cancer
- Bevacizumab, docetaxel, cisplatin
-
Taipei, TaiwanTaipei Medical University Hospital
Dec 2, 2009
Metastatic or Recurrent Squamous Cell Carcinoma of the Esophagus Trial in Ann Arbor (Lapatinib)
Terminated
- Metastatic or Recurrent Squamous Cell Carcinoma of the Esophagus
- Lapatinib
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center
Jul 28, 2008